Adult Vaccines Maintenance of Certification 2015
The IDSA Adult Vaccines MOC Module 2015 is a tool for self-evaluation of medical knowledge regarding adult vaccines and vaccine-preventable diseases. The module consists of 30 multiple-choice questions; the majority contains case-based information and all include educational links and answer rationales. American Board of Internal Medicine (ABIM) diplomates who successfully complete this activity are eligible to receive 10 points toward the self-evaluation of medical knowledge requirement. Participants may also earn a maximum of 10.0 AMA PRA Category 1 Credit(s).™
This CME activity is intended for infectious diseases physicians, ID academicians, and internal medicine physicians.
At the conclusion of this activity, the learner will be able to:
- Identify gaps in medical knowledge regarding adult vaccines and vaccine- preventable diseases where further study is needed for board preparation and patient management
- Improve competence in the area of adult vaccines and vaccine-preventable diseases regarding diagnosis, treatments, and other aspects of patient management
- Evaluate and revise patient management strategies
- Improve clinical decision-making skills related to vaccine implementation
Faculty and Disclosures
Irmgard Behlau, MD, Staff Physician, Infectious Diseases, Mount Auburn Hospital, Harvard Medical School; Research Assistant Professor, Molecular Biology & Microbiology and Ophthalmology, Tufts University School of Medicine; nothing to disclose
Carolyn Bridges, MD, Associate Director for Adult and Influenza Immunizations, Centers for Disease Control and Prevention; nothing to disclose
Thomas Fekete, MD, Professor of Medicine, Section Chief of Infectious Diseases; nothing to disclose
Noreen Hynes, MD, Associate Professor of Medicine, The Johns Hopkins University; panel chair; nothing to disclose
Mary Anne Jackson, MD, Division Director, Infectious Diseases, Children’s Mercy Hospital; American Board of Pediatrics, Medical Editor
Kenneth Kaye, MD, Physician, Brigham and Women’s Hospital; American Medical Seminars, Speaker; Abbott Labs, Allergan, Glaxo SmithKline, Merck: stocks/bonds
Ruth Lynfield, MD, State Epidemiologist and Medical Director, Minnesota Department of Health; nothing to disclose
Kawsar Talaat, MD, Assistant Scientist, Department of International Health, Johns Hopkins University; nothing to disclose
Maureen Tierney, MD, Healthcare Associated Infections Director, Nebraska DHHS; Adjunct Professor UNMC College of Public Health, nothing to disclose
Kathleen Matikonis, MA, IDSA Senior Education Officer; nothing to disclose
IDSA is accredited by the Accreditation Council for Continuing Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
IDSA designates this enduring material for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Physician participation information will be shared with ABIM through ACCME PARS.
- 10.00 ABIM MOC II
- 10.00 AMA PRA Category 1 Credit(s)™